EL SEGUNDO, Calif. — Gov. Gavin Newsom announced Thursday that CalRx biosimilar insulin glargine pens will be available to consumers in California beginning Jan. 1, 2026. The launch comes amid the ...
California has launched a program to manufacture and sell lower-cost insulin to people with diabetes. State officials say consumers will be able to purchase a five-pack of insulin pens for $55 in ...
Litigation over Medtronic Plc’s alleged scheme to avoid $100 million in deal payments by sabotaging sales of a reusable insulin pen ended with an anticlimax Monday. The order formally dismissing the ...
California’s CalRx insulin pens will launch Jan. 1 at $11 each, or $55 for a five-pack The state has invested $100 million to lower insulin costs The effort could save patients $2,000 to $4,000 a year ...
MONDAY, Oct. 20, 2025 (HealthDay News) — California will start selling low-cost insulin Jan. 1, nearly three years after Gov. Gavin Newsom announced a plan to make lifesaving medications more ...
Javascript is required for you to be able to read premium content. Please enable it in your browser settings.
(AP) — Gov. Gavin Newsom said Thursday that California will begin selling affordable insulin under its own label on Jan. 1, nearly three years after he first announced a partnership to sell ...
Hosted on MSN
California To Sell State-Branded, Affordable Insulin
California Governor Gavin Newsom announced that the state will start selling affordable insulin in January to help reduce healthcare costs through state-branded drugs. This initiative follows Newsom’s ...
The state of California is teaming up with the nonprofit generic drug maker Civica Rx and Biocon Biologics to offer an interchangeable biosimilar insulin glargine pen for $11 beginning January 1, 2026 ...
LOS ANGELES — Gov. Gavin Newsom said Thursday that California will begin selling affordable insulin under its own label on Jan. 1, nearly three years after he first announced a partnership to sell ...
LOS ANGELES (AP) — Gov. Gavin Newsom said Thursday that California will begin selling affordable insulin under its own label on Jan. 1, nearly three years after he first announced a partnership to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback